Clinical Trial

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

Name: Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2 — clinical trial record (NCT07278388)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.

Trial Details

NCT Number	NCT07278388
Lead Sponsor	Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions	PASC Post Acute Sequelae of COVID 19, Fatigue
Enrollment	200 participants
Start Date	2025-07-16
Primary Completion	2029-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-12